Sanders blasts Novo Nordisk for ‘outrageous’ price of Ozempic, Wegovy
Citing a JAMA study that found Ozempic could be profitably produced at under $5 per month, Senator Bernie Sanders on Wednesday called on Novo Nordisk to lower prices for the diabetes treatment and the weight-loss drug Wegovy.